Vijaya Diagnostic Centre VIJAYA
Integrated pathology and radiology chain dominant in Telangana and Andhra Pradesh, expanding to Pune and Kolkata
Mapped in 1 theme: Hospitals & Healthcare.
Where Vijaya Diagnostic Centre sits in the supply chain
Vijaya Diagnostic Centre appears in 2 supply-chain layers in one theme, Hospitals & Healthcare.
Hospitals & Healthcare › Pathology labs
OperatorOther companies in this layer
Hospitals & Healthcare › Radiology & imaging
OperatorOther companies in this layer
Revenue and profit
| ₹ Cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 462 | 459 | 548 | 681 | 814 |
| Net profit | 111 | 85 | 120 | 144 | 173 |
Latest-year revenue ₹814 Cr (FY26, company-wide).
Strengths
- One-stop centres doing both lab tests and imaging earn more per patient
- Mostly B2C - walk-in patients and doctor referrals
- Self-funded expansion into new cities
Risks
- Heavy dependence on Hyderabad
- Radiology needs capex and radiologists
Common questions
What does Vijaya Diagnostic Centre do?
Integrated pathology and radiology chain dominant in Telangana and Andhra Pradesh, expanding to Pune and Kolkata.
Where does Vijaya Diagnostic Centre sit in the supply chain?
Vijaya Diagnostic Centre (NSE: VIJAYA) is mapped in 2 supply-chain layers: Pathology labs (Hospitals & Healthcare) and Radiology & imaging (Hospitals & Healthcare).
Who are Vijaya Diagnostic Centre's peers?
In the Pathology labs layer of Hospitals & Healthcare: Dr Lal PathLabs, Metropolis Healthcare, Thyrocare Technologies, Fortis Healthcare and Neuberg Diagnostics (not NSE-listed).
What is Vijaya Diagnostic Centre's market cap and valuation?
As of 6 Nov 2026: market cap ₹15,176 Cr, P/E 74.5x, ROCE 20.5%, ROE 18.3%, dividend yield 0.14%.